Posts by: Ana Pena

News

People with myastenia gravis (MG) whose disease is refractory, or resistant, to conventional therapies, are more likely to have disease flare-ups, visit an emergency room, be hospitalized, or be ... Read more

June 11, 2019June 11, 2019

Differences in Gene Activity May Explain Why Some Patients Have Difficult-to-treat Eye Disease, Study Shows

News

Examining differences in the activity of certain genes may help explain why some patients with myasthenia gravis (MG) develop a difficult-to-treat form of the disease in the eyes. Researchers ... Read more

June 6, 2019June 6, 2019

Dropouts in Placebo Groups Due to Adverse Events Are Low in MG Clinical Trials, Study Shows

News

Placebo-treated myasthenia gravis (MG) patients experience as many adverse events as those receiving an active treatment during clinical trials, but this leads to few participant dropouts — and should ... Read more

April 16, 2019April 16, 2019

Computational Model Identifies Candidate Therapies Based on MG Risk Genes

News

Researchers have identified five candidate therapies for treating myasthenia gravis (MG) by using a new computational model that also predicts key biological processes involved in the disease. The study, “Building ... Read more

March 21, 2019March 21, 2019

Prograf May Be Effective Medication for Myasthenia Gravis, Analysis Shows

News

Prograf (Tacrolimus) may be a beneficial treatment for people with myasthenia gravis (MG), helping reduce steroid use and disease scores, a joint analysis of several studies shows. The review, “Effectiveness ... Read more

January 15, 2019January 15, 2019

MG-ADL Symptom Scale Would Benefit from Questions on Generalized Weakness, Study Says

News

MG-ADL, a patient-reported scale commonly used to address symptom severity in myasthenia gravis (MG), has a poor sensitivity for measuring generalized muscle weakness. Researchers suggest that more questions about ... Read more

January 3, 2019January 3, 2019

Common Clinical Scales Insufficient to Evaluate Swallowing Problems in MG Patients, Study Reports

News

Commonly used clinical scales to measure symptom severity in myasthenia gravis (MG) patients are insufficient to precisely evaluate swallowing problems and predict the risk of silent aspiration, a study ... Read more

October 18, 2018October 18, 2018

Gut Microbiota Differs in Myasthenia Gravis Patients, Pilot Study Reports

News

Gut microbiota is altered in people with myasthenia gravis (MG), opening the door for exploring the use of microbiota-modulating therapies, like probiotics, as potential ways of better managing the disease. ... Read more

October 11, 2018October 11, 2018

Walk Tests a Reliable Measure of Exercise Capacity in MG Patients, Study Suggests

News

Two timed walk tests were found to be highly reliable for the measurement of exercise capacity in patients with mild to moderate generalized myasthenia gravis (MG), a study reports. The ... Read more

September 21, 2018September 21, 2018

Thymus Tumor Elevates Risk of Ocular MG Becoming Generalized, Case Series Finds

News

Thymoma, a tumor of the thymus gland that can be benign or malignant, elevates ocular myasthenia gravis (MG) patients’ risk of developing a generalized form of the disease, a ... Read more

Posts by: Ana Pena

Ana Pena

Refractory MG Poses Burden to U.S. Healthcare System, Needs Better Treatments, Study Finds

Differences in Gene Activity May Explain Why Some Patients Have Difficult-to-treat Eye Disease, Study Shows

Dropouts in Placebo Groups Due to Adverse Events Are Low in MG Clinical Trials, Study Shows

Computational Model Identifies Candidate Therapies Based on MG Risk Genes

Prograf May Be Effective Medication for Myasthenia Gravis, Analysis Shows

MG-ADL Symptom Scale Would Benefit from Questions on Generalized Weakness, Study Says

Common Clinical Scales Insufficient to Evaluate Swallowing Problems in MG Patients, Study Reports

Gut Microbiota Differs in Myasthenia Gravis Patients, Pilot Study Reports

Walk Tests a Reliable Measure of Exercise Capacity in MG Patients, Study Suggests

Thymus Tumor Elevates Risk of Ocular MG Becoming Generalized, Case Series Finds

Pin It on Pinterest